Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Aug 28, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at a specific type of lupus called monogenic lupus in children who develop systemic lupus erythematosus (SLE). The researchers want to understand how common monogenic lupus is in these young patients and to find better ways to diagnose it early. This is important because early detection can lead to better management of the condition.

To participate in the study, children between the ages of birth and 18 years who have been diagnosed with SLE can join, provided they have parental consent. Participants will need to have their medical information available to help with the study. If someone decides to join, they can expect to be part of a research effort that aims to improve understanding and treatment of lupus in children. The trial is currently recruiting participants, and it is open to all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Subjects who meet the following criteria will be allowed to participate in the study:
• • 1. onset age: birth to 18 years;
• • 2. meet the diagnostic criteria of SLE according to ACR(1997), or SLICC(2012), or EULAR/ACR (2019);
• • 3. obtain parental consent.
• Exclusion Criteria:
• • 1. Lack of clinical data;
• • 2. Unable to finish the follow-up.